Showing results (61-70 of 97) with videos related to

Sort By:
Pageof 10
EJNMMI Research|January 24, 2023
Optimization of the radiation dosimetry protocol in Lutetium-177-PSMA therapy: toward clinical implementationSteffie M B Peters, Maaike C T Mink, Bastiaan M Privé, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 22, 2023
Fibroblast activation protein-targeted radionuclide therapy: background, opportunities, and challenges of first (pre)clinical studiesBastiaan M Privé, Mohamed A Boussihmad, Bart Timmermans, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 21, 2021
89Zr-labeled PSMA ligands for pharmacokinetic PET imaging and dosimetry of PSMA-617 and PSMA-I&T: a preclinical evaluation and first in manBastiaan M Privé, Yvonne H W Derks, Florian Rosar, et al.
Cellular Oncology (Dordrecht, Netherlands)|February 3, 2021
Digoxin treatment reactivates in vivo radioactive iodide uptake and correlates with favorable clinical outcome in non-medullary thyroid cancerThomas Crezee, Marika H Tesselaar, James Nagarajah, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 8, 2021
[68Ga]Ga-PSMA-11 PET imaging as a predictor for absorbed doses in organs at risk and small lesions in [177Lu]Lu-PSMA-617 treatmentSteffie M B Peters, Regina Hofferber, Bastiaan M Privé, et al.
Theranostics|September 23, 2024
Lutetium-177-PSMA therapy for recurrent/metastatic salivary gland cancer: a prospective pilot studyNiels J van Ruitenbeek, Maike J M Uijen, Chantal M L Driessen, et al.
The Lancet. Oncology|May 29, 2025
Health-related quality of life, pain, and symptomatic skeletal events with [177Lu]Lu-PSMA-617 in patients with progressive metastatic castration-resistant prostate cancer (PSMAfore): an open-label, randomised, phase 3 trialKarim Fizazi, Michael J Morris, Neal D Shore, et al.
Cancers|May 13, 2023
Head-To-Head Comparison of PET and Perfusion Weighted MRI Techniques to Distinguish Treatment Related Abnormalities from Tumor Progression in GliomaDylan Henssen, Lars Leijten, Frederick J A Meijer, et al.
Clinical Genitourinary Cancer|May 10, 2023
Tumoral Ki67 and PSMA Expression in Fresh Pre-PSMA-RLT Biopsies and Its Relation With PSMA-PET Imaging and Outcomes of PSMA-RLT in Patients With mCRPCBabette I Laarhuis, Marcel J R Janssen, Michiel Simons, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 19, 2025
TGF-β1-based restoration of sodium iodide symporter expression in radioiodine-refractory differentiated thyroid cancer via engineered MSCsYang Han, Viktoria F Koehler, James Nagarajah, et al.
Pageof 10